07:00 , Sep 21, 2015 |  BC Week In Review  |  Clinical News

Axelopran/oxycodone FDC: Clinical trial data

An open-label, 4-way crossover trial in 28 healthy volunteers showed that 10/20 mg axelopran/oxycodone FDC was bioequivalent to axelopran and oxycodone co-administered as 2 separate tablets. Additionally, axelopran did not significantly alter systemic exposure to...